Endurant Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-25,500
Closed -$1.07M 105
2015
Q1
$1.07M Buy
+25,500
New +$1.07M 0.35% 69